47
Participants
Start Date
August 10, 2018
Primary Completion Date
October 5, 2021
Study Completion Date
October 5, 2021
Aflibercept Injection [Eylea]
Intravitreal injection 2 mg Eylea every 4 weeks M0-M2 (loading phase). M3-M12: continue in a pro re nata treatment regimen.
Navigated laser photocoagulation
Navigated laser photocoagulation planned from flourscein angiography.
Department of Ophthalmology, Zealand University Hospital, Roskilde
Department of Ophthalmology, Odense University Hospital, Odense
Collaborators (1)
Danske Regioner
OTHER
Synoptik-Fonden
UNKNOWN
Toyota-Fonden
OTHER
AP Moeller Foundation
OTHER
Yamagata University
OTHER
Queen's University, Belfast
OTHER
Zealand University Hospital
OTHER
Region Sjællands og Region Syddanmarks forskningspulje
UNKNOWN
Odense University Hospital
OTHER